Skip to main content
SpringerLink
Log in

Intrauterine Transfusion

  • Fetal Procedure
  • Published:
Journal of Fetal Medicine

Abstract

The mainstay of management of an Rh isoimmunized pregnancy is the early identification of fetal anemia. Ultrasound middle cerebral artery-peak systolic velocity (MCA-PSV) Doppler measurements are very useful to diagnose severe disease, to time delivery/serial intrauterine transfusions, and eliminate need of amniocentesis/cordocentesis. Fetal blood sampling is done if the fetus is hydropic or MCA-PSV is >1.5 MoM. Blood is kept ready for transfusion if fetal anemia is detected (hematocrit <30 %). Intravascular transfusion is preferred, especially in hydropic fetuses. Rarely, intraperitoneal transfusion is performed in certain situations when the approach to cord is difficult—posterior placenta, obesity, and very early gestation. Blood is absorbed through the lymphatics. Ultrasound and color Doppler is done for fetal heart activity, placental site, cord insertion, and accessible site. The needle path is mapped and decision is taken on where to enter the cord—cord insertion/free loop/intrahepatic portion site. A 20 gauge long needle is inserted under continuous ultrasound guidance into the umbilical vein, 2–3 mL blood aspirated for hemoglobin, packed cell volume, and blood group. Necessary volume of packed O−ve, irradiated red blood cell (hematocrit of 75–80 %) is then transfused. Fetal monitoring is done by serial ultrasound for anemia, MCA-PSV to time next transfusion, and fetal wellbeing—daily kick counts, ultrasound, and electronic biophysical profile. Neonatal management is by intensive fetal anemia and jaundice monitoring, use of intravenous immunoglobulin, exchange transfusion, and phototherapy. The improvement in outcome of Rh immunized fetuses is primarily due to improved expertise, better ultrasound machines, intrauterine blood transfusion, and improved neonatal care. From July 1997 to September 2015, there were 1022 transfusions performed in one Unit at AIIMS, with an overall successful outcome of 90–94 %. Fetal survival is low if hydropic or with first transfusion at 20 weeks or less. Care during the procedure will help to further improve safety. In conclusion, treatment of fetal anemia in Rh isoimmunization by ultrasound-guided fetal blood transfusions is relatively safe in experienced hands, permits a near-term delivery in majority of cases of this potentially life-threatening fetal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Clarke CA, Mollison PL Whitfield AG. Deaths from rhesus haemolytic disease in England and Wales in 1982 and 1983. Br Med J (Clin Res Ed). 1985;291(6487):17–9.

  2. Rodeck CH, Kemp JR, Holman CA, Whitmore DN, Karnicki J, Austin MA. Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunisation. Lancet. 1981;1(8221):625–7.

    Article  CAS  PubMed  Google Scholar 

  3. Rodeck CH, Nicolaides KH, Warsof SL, Fysh WJ, Gamsu HR, Kemp JR. The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol. 1984;150(6):769–74.

    Article  CAS  PubMed  Google Scholar 

  4. de Crespigny LC, Robinson HP, Quinn M, Doyle L, Ross A, Cauchi M. Ultrasound-guided fetal blood transfusion for severe rhesus isoimmunization. Obstet Gynecol. 1985;66(4):529–32.

    PubMed  Google Scholar 

  5. Jacquetin B, Meyer JL, Urbain MF, Jouve P, Vanlieferingen P. Intrauterine exchange transfusion of the fetus under ultrasound guidance: first successful report. Fetal Diagn Ther. 1986;1(4):180–4.

    Article  CAS  Google Scholar 

  6. Buckshee K, Bhatla N, Paul VK. Successful ultrasound-guided intrauterine blood transfusion in severe non-immune hydrops fetalis. Int J Gynaecol Obstet. 1990;32(2):153–6.

    Article  CAS  PubMed  Google Scholar 

  7. Dadhwal V, Deka D, Gurunath S, Mittal S, Paul VK, Deorari A. Treatment of fetal anemia in Rh isoimmunized pregnancies with intrauterine fetal blood transfusion. J Obstet Gynecol India. 2010;60(2):135–40.

    Article  Google Scholar 

  8. Deka D, Sharma KA, Dadhwal V, Singh A, Kumar G, Vanamail P. Direct fetal intravenous immunoglobulin infusion as an adjunct to intrauterine fetal blood transfusion in rhesus-allommunized pregnancies: a pilot study. Fetal Diagn Ther. 2013;34(3):146–51.

    Article  PubMed  Google Scholar 

  9. Zimmerman R, Carpenter RJ Jr, Durig P, Mari G. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat. BJOG. 2002;109(7):746–52.

    Article  PubMed  Google Scholar 

  10. Papantoniou N, Daskalakis G, Anastasakis E, Marinopoulos S, Mesogitis S, Antsaklis A. Increasing the noninvasive management of rhesus isoimmunization. Int J Gynaecol Obstet. 2008;101(3):281–4.

    Article  PubMed  Google Scholar 

  11. Mari G. Middle cerebral artery peak systolic velocity: is it the standard of care for the diagnosis of fetal anemia? J Ultrasound Med. 2005;24(5):697–702.

    PubMed  Google Scholar 

  12. Inglis SR, Lysikiewicz A, Sonnenblick AL, Streltzoff JL, Bussel JB, Chervenak FA. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization. Am J Perinatol. 1996;13(1):27–33.

    Article  CAS  PubMed  Google Scholar 

  13. Radunovic N, Lockwood CJ, Alvarez M, Plecas D, Chitkara U, Berkowitz RL. The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol. 1992;79(3):390–3.

    Article  CAS  PubMed  Google Scholar 

  14. Cheong YC, Goodrick J, Kyle PM, Soothill P. Management of anti-Rhesus-D antibodies in pregnancy: a review from 1994 to 1998. Fetal Diagn Ther. 2001;16(5):294–8.

    Article  CAS  PubMed  Google Scholar 

  15. van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988–1999. Acta Obstet Gynecol Scand. 2004;83(8):731–7.

    Article  PubMed  Google Scholar 

  16. Mesogitis S, Daskalakis G, Pilalis A, Papantoniou N, Antsaklis A. Fetal intravascular transfusion for hydropic disease due to rhesus isoimmunization. Fetal Diagn Ther. 2005;20(5):431–6.

    Article  PubMed  Google Scholar 

  17. van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, Kanhai HH. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol. 2005;192(1):171–7.

    Article  PubMed  Google Scholar 

  18. Dodd JM, Windrim RC, van Kamp IL. Techniques of intrauterine fetal transfusion for women with red-cell isoimmunisation for improving health outcomes. Cochrane Database Syst Rev. 2012;9:CD007096.

    PubMed  Google Scholar 

  19. Orsini LF, Pilu G, Calderoni P, Zucchini S, Tripoli N, Pittalis MC, et al. Intravascular intrauterine transfusion for severe erythroblastosis fetalis using different techniques. Fetal Diagn Ther. 1988;3(1–2):50–9.

    Article  CAS  Google Scholar 

  20. Craparo FJ, Bonati F, Gementi P, Nicolini U. The effects of serial intravascular transfusions in ascitic/hydropic RhD-alloimmunized fetuses. Ultrasound Obstet Gynecol. 2005;25(2):144–8.

    Article  CAS  PubMed  Google Scholar 

  21. Deka D, Dadhwal V, Sharma AK, Shende U, Agarwal S, Agarwal R, et al. Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization. Arch Gynecol Obstet. 2015 (Epub ahead of print).

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, CI/17, AIIMS, Ansari Nagar, New Delhi, 110029, India

    Dipika Deka

Authors
  1. Dipika Deka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dipika Deka.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deka, D. Intrauterine Transfusion. J. Fetal Med. 3, 13–17 (2016). https://doi.org/10.1007/s40556-016-0072-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40556-016-0072-4

Keywords

Search

Navigation